GB201503218D0 - Particles comprising fusion proteins - Google Patents

Particles comprising fusion proteins

Info

Publication number
GB201503218D0
GB201503218D0 GB201503218A GB201503218A GB201503218D0 GB 201503218 D0 GB201503218 D0 GB 201503218D0 GB 201503218 A GB201503218 A GB 201503218A GB 201503218 A GB201503218 A GB 201503218A GB 201503218 D0 GB201503218 D0 GB 201503218D0
Authority
GB
United Kingdom
Prior art keywords
particles
fusion proteins
fusion
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB201503218A
Other versions
GB2535753A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NATIVE ANTIGEN Co
Original Assignee
NATIVE ANTIGEN Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NATIVE ANTIGEN Co filed Critical NATIVE ANTIGEN Co
Priority to GB1503218.8A priority Critical patent/GB2535753A/en
Publication of GB201503218D0 publication Critical patent/GB201503218D0/en
Publication of GB2535753A publication Critical patent/GB2535753A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/28011—Hepeviridae
    • C12N2770/28111—Hepevirus, e.g. hepatitis E virus
    • C12N2770/28123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
GB1503218.8A 2015-02-26 2015-02-26 Particles comprising fusion proteins Withdrawn GB2535753A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1503218.8A GB2535753A (en) 2015-02-26 2015-02-26 Particles comprising fusion proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1503218.8A GB2535753A (en) 2015-02-26 2015-02-26 Particles comprising fusion proteins

Publications (2)

Publication Number Publication Date
GB201503218D0 true GB201503218D0 (en) 2015-04-15
GB2535753A GB2535753A (en) 2016-08-31

Family

ID=52876151

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1503218.8A Withdrawn GB2535753A (en) 2015-02-26 2015-02-26 Particles comprising fusion proteins

Country Status (1)

Country Link
GB (1) GB2535753A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112480269A (en) * 2020-12-11 2021-03-12 杭州爱谨生物科技有限公司 Rabbit viral hemorrhagic disease virus VP10-VP60 recombinant protein and preparation method and application thereof
CN112724205A (en) * 2021-02-01 2021-04-30 山西省中医药研究院（山西省中医院） Method for preparing virus-like particles from hepatitis E virus (HCV) 239 protein and application of virus-like particles

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE16703049T1 (en) 2015-01-15 2018-07-12 University Of Copenhagen VIRUSUAL PARTICLES WITH EFFICIENT EPITOPHONE
WO2017071713A1 (en) 2015-10-30 2017-05-04 University Of Copenhagen Virus like particle with efficient epitope display
EP3600397A4 (en) * 2017-03-28 2021-01-27 Children's Hospital Medical Center Norovirus s particle based vaccines and methods of making and using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175099A (en) * 1989-05-17 1992-12-29 Research Corporation Technologies, Inc. Retrovirus-mediated secretion of recombinant products
US7763258B2 (en) * 1997-05-20 2010-07-27 The Trustees Of The University Of Pennsylvania Virus-like particles (VLPs) comprising heterologous multiple membrane spanning proteins
US8574590B2 (en) * 2003-07-30 2013-11-05 Integral Molecular, Inc. Lipoparticles comprising proteins, methods of making, and using the same
WO2010062757A1 (en) * 2008-11-03 2010-06-03 Ligocyte Pharmaceuticals, Inc. Improved methods for isolating enveloped virus-based vlps free of infectious agents
US20130017210A1 (en) * 2010-03-17 2013-01-17 Stc.Unm Display of antibody fragments on virus-like particles of rna bacteriophages
US20120052082A1 (en) * 2010-04-09 2012-03-01 Zetra Biologicals, LLC Cross-protective influenza vaccine
AR092796A1 (en) * 2012-02-16 2015-05-06 Vlp Therapeutics Llc VIRAL TYPE PARTICULATED COMPOSITION

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112480269A (en) * 2020-12-11 2021-03-12 杭州爱谨生物科技有限公司 Rabbit viral hemorrhagic disease virus VP10-VP60 recombinant protein and preparation method and application thereof
CN112724205A (en) * 2021-02-01 2021-04-30 山西省中医药研究院（山西省中医院） Method for preparing virus-like particles from hepatitis E virus (HCV) 239 protein and application of virus-like particles
CN112724205B (en) * 2021-02-01 2023-05-02 山西省中医药研究院（山西省中医院） Method for preparing virus-like particles from C hepatitis E virus 239 protein and application thereof

Also Published As

Publication number Publication date
GB2535753A (en) 2016-08-31

Similar Documents

Publication Publication Date Title
HK1244019A1 (en) Fusion proteins
HRP20190028T1 (en) Interleukin-2 fusion proteins and uses thereof
HK1250043A1 (en) Gitrl fusion proteins and uses thereof
ZA201701810B (en) Sirp-alpha immunoglobulin fusion proteins
GB201509413D0 (en) Fusion protein
HK1232136A1 (en) P97-ids fusion proteins p97-ids
HK1246316A1 (en) Cytokine fusion proteins
GB201504691D0 (en) Fusion protein
ZA202003845B (en) Fusion proteins
GB201503218D0 (en) Particles comprising fusion proteins
HK1257937A1 (en) Fusion protein
SG11201606501PA (en) Nanobody-fluorescent protein fusion
GB201602850D0 (en) Fusion proteins
GB201713537D0 (en) Fusion Polypeptide
GB201503789D0 (en) Fusion polypeptide

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)